english.prescrire.org

Welcome to the Prescrire in English website

Reliable, rigorously independent information on treatments and healthcare strategies,
to enable fully informed decision-making. Prescrire is financed by its subscribers.
No grants, no advertising. No shareholders, no sponsors.

In Prescrire's Spotlight

Equine oestrogens + bazedoxifene (Duavive°) and menopause. Inadequately evaluated harms

1 July 2017

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
In the July issue of Prescrire International: The adverse effects of the cytotoxic temsirolimus and the opioid pholcodine

1 July 2017

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Pertuzumab: of variable benefit depending on the type of breast cancer

1 July 2017

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Pregnancy and Graves' disease: opt for treatments posing the lowest maternal and fetal risks

1 July 2017

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Who are we? A non-profit continuing education organisation, committed to better patient care

1 July 2017

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Global "No Free Lunch" Conference in Berlin 15-17 September 2017: "How do conflicts of interest harm health around the world?"

1 July 2017

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
"Preventing Overdiagnosis 2017: Towards Responsible Global Solutions": an international conference in Quebec City,
17-19 August 2017

1 June 2017

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
From the editors of Prescrire International: Top texts of 2015-2016

1 December 2016

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Receive the free, monthly "Independent Drug & Healthcare Newsletter"

1 September 2016

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Subscribe online for full access to content from Prescrire International

1 September 2016